4 completed, 2 recruiting, 2 terminated, 1 unknown. 3 Phase 2, 2 Not applicable, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Lugol's solution: new trials by email Literature Review of Lugol's solution trials Research Report on Lugol's solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter Iodine-Potassium Iodide 5%-10% Oral and Topical Solution - Hyperthyroidism | Phase 3 | Recruiting | Jan Calissendorff | 182 | 2021-11-18 | 2026-02-10 |
| Lower Lugol's Solution Concentration on Reducing the Adverse Symptoms of Chromoendoscopy With Iodine Staining 1.2% Lugol's solution, 1.0% Lugol's solution, 0.8% Lugol's solution - Mucosal Irritation, Image Quality | Phase 2 | Completed | Shandong University | 200 | 2017-09-01 | 2020-01-10 |
| Different Lugol's Solution Concentration for Image Quality of Esophageal Lesions in Chromoendoscopy With Iodine Staining 1.2% Lugol's solution, 1.0% Lugol's solution, 0.8% Lugol's solution - Image Quality of Early Esophageal Squamous Neoplasia, Endoscopists'Subjective Assessments | Phase 4 | Unknown | Shandong University | 50 | 2017-06-01 | 2017-06-08 |
| RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection Radiofrequency ablation, Endoscopy, Lugol's Solution (1.5%) - Esophageal Squamous Cell Neoplasm | Not applicable | Recruiting | E-DA Hospital | 100 | 2016-04-18 | 2023-03-03 |
| International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device Iobenguane I -123 Injection, Implantable Cardioverter Defibrillator, Thyroid blocking - Heart Failure | Phase 3 | Terminated | GE Healthcare | 395 | 2015-12-30 | 2019-05-22 |
| Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women Visual Inspection with Acetic Acid, Visual Inspection with Lugol's Iodine - Cervical Intraepithelial Neoplasia, Cervical Cancer | Not applicable | Completed | University of California, San Francisco | 654 | 2011-10-01 | 2014-09-11 |
| Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy Bexxar (tositumomab), External beam radiotherapy (XRT), Potassium Iodide (KI) - Lymphoma, Non-Hodgkin | Phase 2 | Terminated | Stanford University | 8 | 2007-01-01 | 2017-03-29 |
| Effect of Lugol's Solution in the Patients With Graves' Disease lugol's solution - Graves Disease | Completed | Istanbul University | 36 | 2005-09-01 | 2008-10-20 | |
| Phase 2 Study of Bexxar in Relapsed/Refractory DLCL Bexxar, Acetaminophen, Diphenhydramine - Lymphoma | Phase 2 | Completed | Susan Knox | 9 | 2004-09-01 | 2017-03-30 |
Esophageal Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Graves Disease (1) · Heart Failure (1) · Hyperthyroidism (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Recurrence (1) · Uterine Cervical Dysplasia (1) · Uterine Cervical Neoplasms (1)
Shandong University (2) · E-DA Hospital (1) · GE Healthcare (1) · Istanbul University (1) · Jan Calissendorff (1) · Stanford University (1) · Susan Knox (1) · University of California, San Francisco (1)
United States (3) · China (2) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Kenya (1) · Netherlands (1) · Poland (1) · Spain (1) · Sweden (1) · Taiwan (1)
Susan J Knox (2) · Xiuli Zuo, PhD (2) · Jan Calissendorff, MD, PhD (1)
PMID 11474389, PMID 12297767, PMID 19340732, PMID 19474425, PMID 20669074, PMID 21455869, PMID 21679712, PMID 21839994, PMID 22423666, PMID 24668102, PMID 25257127, PMID 25668428, PMID 25849627, PMID 26656367, PMID 37094943, PMID 39119004, PMID 39521094
2015 (1)